A Study for the Risk Factors of Hepatocellular Carcinoma in Cirrhotic Patients with Chronic Hepatitis B

被引：0
|
作者：
Zhang, Yuanqing [1 ]
Peng, Lijun [1 ,2 ]
Cao, Yirong [1 ]
Zeng, Zhiping [1 ]
Wu, Yujing [1 ]
Shi, Hong [1 ]
Chen, Shiyao [1 ]
Wang, Jiyao [1 ]
Friedman, Scott L. [1 ,3 ]
Sninsky, John J. [1 ,4 ]
Guo, Jinsheng [1 ]
机构：
[1] Fudan Univ, Zhong Shan Hosp, Div Digest Dis, Shanghai 200433, Peoples R China
[2] Linyi Peoples Hosp, Dept Gastroenterol, Linyi, Peoples R China
[3] Mt Sinai Hosp, Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY 10029 USA
[4] Celera Quest Diagnost, Alameda, CA USA
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
131
引用
收藏
页码：275A / 276A
页数：2
相关论文
共 50 条
  • [41] Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
    Lee, Han Ah
    Seo, Yeon Seok
    Kim, Seung Up
    GASTROENTEROLOGY, 2020, 158 (08) : 2310 - 2311
  • [42] Risk calculators for hepatocellular carcinoma in patients affected with chronic hepatitis B in Asia
    Yang, Hwai-I
    Lee, Mei-Hsuan
    Liu, Jessica
    Chen, Chien-Jen
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (20) : 6244 - 6251
  • [43] Annual Incidence for Hepatocellular Carcinoma (HCC) in Non-Cirrhotic Patients With Chronic Hepatitis B (CHB) and Cirrhotic Patients of All Etiologies
    Do, Ailinh L.
    Wong, Carrie R.
    Nguyen, Vincent G.
    Garcia, Ruel T.
    Trinh, Huy N.
    Kin, Kevin
    Nguyen, Huy A.
    Nguyen, Khanh K.
    Levitt, Brian S.
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2011, 140 (05) : S920 - S920
  • [44] Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B
    Hsu, Yao-Chun
    Wu, Chun-Ying
    Lane, Hsien-Yuan
    Chang, Chi-Yang
    Tai, Chi-Ming
    Tseng, Cheng-Hao
    Lo, Gin-Ho
    Perng, Daw-Shyong
    Lin, Jaw-Town
    Mo, Lein-Ray
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (07) : 1920 - 1927
  • [45] Hepatocellular Carcinoma Surveillance Rates in Non-Cirrhotic Patients with Chronic Hepatitis B in the United States
    Goldberg, David S.
    Valderama, Adriana
    Kamalakar, Rajesh
    Sansgiry, Sujit S.
    Babajanyan, Svetlana
    Lewis, James D.
    HEPATOLOGY, 2014, 60 : 991A - 991A
  • [46] Determinants for the development of cirrhotic complications and hepatocellular carcinoma (HCC) in Chinese patients with chronic hepatitis B.
    Yuen, MF
    Yuan, HJ
    Wong, DKH
    Hui, CK
    Wong, WM
    Chan, AOO
    Wong, BCY
    Lai, KC
    Lai, CL
    HEPATOLOGY, 2002, 36 (04) : 525A - 525A
  • [47] Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B
    Yuen, M. F.
    Tanaka, Y.
    Fong, D. Y.
    Fung, J.
    Wong, D. K.
    Yuen, J. C.
    But, D. Y.
    Chan, A. O.
    Wong, B. C.
    Mizokami, M.
    Lai, C. L.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S252 - S252
  • [48] Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B
    Yuen, Man-Fung
    Tanaka, Yasuhito
    Fong, Daniel Yee-Tak
    Fung, James
    Wong, Danny Ka-Ho
    Yuen, John Chi-Hang
    But, David Ylu-Kuen
    Chan, Annie On-On
    Wong, Benjamin Chun-Yu
    Mjzokami, Masashi
    Lai, Ching-Lung
    JOURNAL OF HEPATOLOGY, 2009, 50 (01) : 80 - 88
  • [49] Prevention of hepatocellular carcinoma in patients with chronic hepatitis B
    Conrado M Fernández-Rodríguez
    María Luisa Gutiérrez-García
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2014, (03) : 175 - 182
  • [50] Risk of hepatocellular carcinoma in cirrhotic hepatitis B virus patients during nucleoside/nucleotide analog therapy
    Orito, Etsuro
    Hasebe, Chitomi
    Kurosaki, Masayuki
    Osaki, Yukio
    Joko, Kouji
    Watanabe, Hiroshi
    Kimura, Hiroyuki
    Nishijima, Norihiro
    Kusakabe, Atsunori
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2015, 45 (08) : 872 - 879
12345